Neurelis
Founded in 2007, Neurelis is a specialty pharmaceutical company based in Encinitas, California. It focuses on licensing, developing, and commercializing product candidates for epilepsy and the broader central nervous system market. The company differentiates itself by applying novel technologies to enhance therapeutic benefits and improve patient care.
Top Regions
Top Stages
https://app.dealroom.co/companies/***
https://crunchbase.com/organization/***
https://linkedin.com/company/***
1 past transactions
Aegis Therapeutics
Acquisition in 2018
Aegis Therapeutics, LLC is a San Diego-based company specializing in drug delivery and drug formulation technologies. Founded in 2003, the company focuses on commercializing its patented technologies through strategic partnerships with pharmaceutical and biopharmaceutical firms. Aegis offers Intravail, a drug delivery technology that facilitates the non-invasive administration of a wide range of protein, peptide, and non-peptide drugs, enabling delivery through oral, buccal, dermal, and intranasal routes. Additionally, the company provides ProTek, which creates stable, homogeneous dosage forms for peptide and protein therapeutics, and Hydrogels, which are self-assembling aqueous hydrogels designed for enhanced transdermal or transmucosal drug delivery. Aegis Therapeutics aims to improve patient experience by eliminating the need for injections and the associated complications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.